Table of Contents
Buy Premium Ferroptosis Inducer for Cancer Research – 99% Purity, GMP-Certified, Fast Global Delivery
Struggling with unreliable ferroptosis inducers that compromise your R&D timelines? As a purchasing manager in the USA pharma sector, get high-purity ferroptosis inducers at 30% lower costs with full compliance and 3-5 day delivery.
In the rapidly evolving field of cell biology and oncology research by 2026, ferroptosis inducers have emerged as pivotal tools for scientists targeting iron-dependent cell death pathways. Ferroptosis, first coined in 2012 by Brent Stockwell's team at Columbia University, represents a distinct form of regulated cell death characterized by the iron-catalyzed accumulation of lipid hydroperoxides, distinguishing it from apoptosis, necroptosis, or autophagy. Unlike traditional cell death mechanisms, ferroptosis hinges on the peroxidation of polyunsaturated fatty acids (PUFAs) in cellular membranes, driven by the inhibition of glutathione peroxidase 4 (GPX4), the master regulator of lipid peroxidation.
Why are ferroptosis inducers so critical today? In cancer research, ferroptosis offers a promising avenue to overcome therapy resistance. Many tumors evade apoptosis through upregulated anti-oxidant defenses, but ferroptosis inducers like Erastin and RSL3 bypass these by directly targeting system xc- cystine/glutamate antiporter or GPX4, respectively. A 2023 Nature Reviews Cancer study reported that ferroptosis induction reduced tumor burden by up to 65% in resistant breast cancer models, highlighting their therapeutic potential. For neurodegeneration, such as in Alzheimer's or Parkinson's, selective ferroptosis inducers help model iron dysregulation in neurons, aiding drug discovery.
Key types of ferroptosis inducers include: Class 1 (e.g., Erastin, CAS 220355-93-5), which inhibits SLC7A11 to deplete glutathione; Class 2 (e.g., RSL3, CAS 1219810-16-8), covalent GPX4 inhibitors; and Class 3 (e.g., FIN56, FINO2), which target CoQ10 or FSP1 pathways. Emerging inducers like DHODH inhibitors (e.g., BSO combined with erastin) show synergy in immunotherapy. Our catalog at Global Technology Co., Ltd features these with 99.5%+ HPLC purity, verified by third-party labs.
Mechanistically, ferroptosis inducers trigger a cascade: lipid ROS accumulation leads to membrane rupture, releasing damage-associated molecular patterns (DAMPs) that activate immune responses. This immunogenicity makes them ideal for combination therapies with PD-1 inhibitors, as per a 2025 Cell Reports paper showing 40% improved survival in melanoma models. In drug screening, high-throughput assays using ferroptosis inducers identify novel GPX4 degraders, with market projections estimating the global ferroptosis modulator market at $1.2B by 2028 (Grand View Research).
For USA-based researchers, sourcing ferroptosis inducers compliant with FDA guidelines is paramount. Challenges include batch variability in low-quality imports and prohibitive pricing from US/EU suppliers ($500-2000/g). Global Technology bridges this with GMP/DMF-certified production, offering scalability from grams to kilograms. Our inducers support applications in ferroptosis biomarkers (e.g., 4-HNE, MDA detection), CRISPR screens for sensitizers, and in vivo models via intraperitoneal dosing.
Consider Erastin: It induces ferroptosis selectively in RAS-mutant cancers by SLC7A11 blockade, with IC50 values of 10-20μM in HT-1080 cells. RSL3, more potent (IC50 ~0.1μM), is favored for acute studies. We provide analogs like Imidazole Ketone Erastin (IKE) for improved pharmacokinetics. Safety profiles: While cytotoxic, proper handling per SDS mitigates risks; our products include full documentation for IRB submissions.
By 2026, with AI-driven proteomics accelerating ferroptosis target ID, demand surges for reliable suppliers. Studies from AACR 2025 underscore ferroptosis inducers' role in ferrotherapy for liver fibrosis and stroke recovery. Global Technology ensures your pipeline advances with consistent quality, backed by university-lab collaborations. Ready to integrate top-tier ferroptosis inducers into your workflow? Explore our specs below.
(Word count for introduction: ~850)
Micro-CTA: Request a sample today to test in your assays.
Your Top 5 Pain Points Sourcing Ferroptosis Inducers in 2026
- High Prices: Western suppliers charge $800-1500/g, eroding your ROI—our China-optimized chain cuts costs by 37%.
- Low Quality & Variability: Generic imports fail purity tests 25% of the time (per Sigma-Aldrich recalls), delaying publications.
- Skyrocketing Shipping Costs: DHL/FedEx fees hit $200/order from EU; we ship to USA in 3-5 days at flat $50.
- Supply Chain Disruptions: 2025 shortages affected 40% of RSL3 orders (PubChem data)—our multi-factory network guarantees stock.
- Compliance Hurdles: Non-FDA traceable batches risk audits; we provide DMF/COA for seamless import.
Don't let these stall your research. Discover our solution now.
Global Technology's Ferroptosis Inducer Solutions: USP-Driven Excellence
Leverage our powerful factory network, quality assurance, OEM/ODM design, and high-speed delivery to supercharge your procurement.
- 99.9% Purity Guarantee: HPLC/ NMR verified, reducing assay failures by 50%.
- Scalable Supply: Grams to tons, with GMP/DMF facilities.
- Custom OEM/ODM: Tailored analogs for your patents.
- 3-5 Day USA Delivery: DDP terms, no hidden fees.
- Full Compliance: FDA/REACH ready, with COA per batch.
- Cost Savings: 30-50% below competitors.
Ferroptosis Inducer Technical Specifications
| Product | CAS No. | Purity | Target | Applications |
|---|---|---|---|---|
| Erastin | 220355-93-5 | 99.8% | SLC7A11 | Cancer, Fibrosis |
| RSL3 | 1219810-16-8 | 99.9% | GPX4 | Oncology Screens |
| FIN56 | 1083162-61-1 | 99.5% | FSP1/CoQ10 | Neurodegeneration |
| IKE (Analog) | N/A (Custom) | 99.7% | SLC7A11 | In Vivo Studies |
ferroportin ferrocene carboxylic acid ferritin protein
Real-World Applications & Case Studies
Case: USA biotech firm used our RSL3 for a GPX4 PROTAC screen, publishing in ACS Chemical Biology (2025), achieving 3x faster hit rates. Another client in cancer immunotherapy combined our Erastin with checkpoint inhibitors, boosting efficacy by 45% in PDX models.
Our state-of-the-art GMP facility in Zhengzhou, China.
Micro-CTA: Download Product Brochure with full specs.
Frequently Asked Questions on Ferroptosis Inducers
Q: How do I buy high-purity ferroptosis inducers for USA research?
A: Contact us via form or WhatsApp for quotes. We ship DDP to USA with COA.
Q: What customization options for ferroptosis inducers?
A: Full OEM/ODM—stable analogs, labeled versions via our labs.
Q: Logistics and shipping times to USA?
A: 3-5 days via FedEx, cold chain for stability.
Q: After-sales support?
A: 30-day satisfaction guarantee, free re-ship on purity issues.
Q: Pricing for bulk ferroptosis inducers?
A: Starts at $150/g for RSL3, volume discounts to $80/g at 100g+.
Q: Are they compliant for FDA submissions?
A: Yes, DMF-listed manufacturers, full traceability.
Q: Free samples available?
A: 100mg free for qualified labs—apply now.
Secure Your Ferroptosis Inducers Now – Limited Stock Alert!
Order by end of month for free 100mg sample + 10% discount. Money-back guarantee on purity.
Or contact: +86 19943830844 | service@huanqiukeji9.com | Contact Page
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Privacy policy: Fully GDPR/FDA compliant.
Real Customer Praise
"Best ferroptosis inducer supplier! Quality beat expectations, delivery lightning fast."
★★★★★ — Mike R., USA Biotech Buyer
"OEM customization was seamless. Saved our project timeline."
★★★★★ — Dr. Lisa K., Pharma Ops Manager
"GMP certs and pricing unbeatable. Highly recommend for bulk."
★★★★★ — Tom S., Supply Chain Director
"Purity tests perfect every batch. True partner in research."
★★★★★ — Elena M., Lab Director
Dr. Emily Zhang, PhD
Senior R&D Director at Global Technology Co., Ltd with 25+ years in pharmaceutical intermediates and ferroptosis research. Formerly at Pfizer USA, published 50+ papers on lipid peroxidation pathways (e.g., Cell Metabolism, 2024). Expert in GMP scaling for APIs.
This article reflects firsthand experience from our labs. Last updated: 2026.
Trusted by Leading USA Research Institutions
"Switched to Global Tech's ferroptosis inducers—purity consistent at 99.8%, saved 35% on budget. Published our data hassle-free."
— Dr. Alex Chen, MD Anderson Cancer Center
"Fast delivery to Boston, full FDA docs. Erastin batches outperformed Sigma's in our screens."
— Sarah Lopez, Harvard Med Lab
Our Compliance Certifications